ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 63 filers reported holding ADC THERAPEUTICS SA in Q4 2022. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,377,275 | -22.4% | 2,650,251 | +86.1% | 0.00% | -50.0% |
| Q2 2023 | $3,061,920 | +87458.5% | 1,424,149 | -20.6% | 0.00% | 0.0% |
| Q1 2023 | $3,497 | -73.2% | 1,793,192 | -47.3% | 0.00% | -71.4% |
| Q4 2022 | $13,060 | -99.4% | 3,401,120 | +709.3% | 0.01% | +600.0% |
| Q3 2022 | $2,026,000 | +339.5% | 420,253 | +625.0% | 0.00% | – |
| Q2 2022 | $461,000 | -43.4% | 57,965 | +43.6% | 0.00% | – |
| Q4 2021 | $815,000 | -14.2% | 40,367 | +36.0% | 0.00% | -100.0% |
| Q4 2020 | $950,000 | -9.3% | 29,679 | -6.5% | 0.00% | 0.0% |
| Q3 2020 | $1,047,000 | +50.2% | 31,747 | +113.3% | 0.00% | 0.0% |
| Q2 2020 | $697,000 | – | 14,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $9,430,000 | 5.29% |
| GCM Grosvenor Holdings, LLC | 1,298,012 | $10,319,000 | 2.33% |
| Redmile Group, LLC | 7,512,029 | $59,721,000 | 2.28% |
| MPM BioImpact LLC | 334,384 | $2,658,000 | 0.74% |
| Indie Asset Partners, LLC | 93,989 | $747,000 | 0.66% |
| Eventide Asset Management | 1,879,959 | $14,946,000 | 0.32% |
| Walleye Capital LLC | 888,700 | $7,065,000 | 0.20% |
| Endurant Capital Management LP | 58,967 | $469,000 | 0.16% |
| HHLR ADVISORS, LTD. | 500,000 | $3,975,000 | 0.08% |
| Matrix Capital Management Company, LP | 400,000 | $3,180,000 | 0.07% |